Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Volitionrx (VNRX) Operating Expenses (2019 - 2025)

Volitionrx (VNRX) has disclosed Operating Expenses for 9 consecutive years, with $5.7 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Operating Expenses fell 9.69% year-over-year to $5.7 million, compared with a TTM value of $24.2 million through Sep 2025, down 22.69%, and an annual FY2024 reading of $28.3 million, down 23.13% over the prior year.
  • Operating Expenses was $5.7 million for Q3 2025 at Volitionrx, down from $6.7 million in the prior quarter.
  • Across five years, Operating Expenses topped out at $9.8 million in Q2 2023 and bottomed at $5.7 million in Q3 2025.
  • Average Operating Expenses over 5 years is $7.6 million, with a median of $7.8 million recorded in 2022.
  • The sharpest move saw Operating Expenses skyrocketed 68.43% in 2021, then crashed 33.52% in 2024.
  • Year by year, Operating Expenses stood at $8.8 million in 2021, then fell by 7.6% to $8.1 million in 2022, then rose by 10.51% to $9.0 million in 2023, then plummeted by 33.52% to $6.0 million in 2024, then decreased by 4.1% to $5.7 million in 2025.
  • Business Quant data shows Operating Expenses for VNRX at $5.7 million in Q3 2025, $6.7 million in Q2 2025, and $5.8 million in Q1 2025.